xph.ph

Elgin Park senior boys AAA volleyball squad finished off their regular season by bringing home the South Frasers regional banner. They now head to triple A provincials Nov. 27-30 in Oak Bay on Vancouver Island. After a season where the team started strong, but "had a little bit of a dip," according to assistant coach Melissa Bonn, who coaches the team with head coach Matt Ekholm, the team performed some team-building exercises, switched up some positions and roles, and are now ranked second in B.C. heading into the provincial championships. The final, vs. Delta Secondary, was a back-and-forth effort where both teams put in great effort, Bonn noted, with half the gym cheering for Elgin, the other, for Delta. "It was such a great game... we dominated the first two sets. We just played really well," she said of the four-set final. "The team not only won the banner, but they held onto their No. 2 ranking going into the provincials next week," said Bonn. "It was an amazing game filled with great kills and amazing extra-effort defence." Elgin's playoff all-stars were Rowan Hartshorne and Max Grantham, with the MVP going to Charlie Lang-Gould. Bonn also credited Elgin Park P.E. teacher Mike Jamieson for helping to build the volleyball program. "I'm unbelievably proud of them," she said of the team. "They battled through adversity and supported each other the entire time."THOUSAND OAKS, Calif. , Dec. 10, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the first quarter of 2025. The dividend will be paid on March 7, 2025 , to all stockholders of record as of the close of business on February 14, 2025 . About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions . Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ® , and it is also part of the Nasdaq-100 Index ® , which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. For more information, visit Amgen.com and follow Amgen on X , LinkedIn , Instagram , TikTok , YouTube and Threads . Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeiGene, Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, Inc., or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon's business, performance and opportunities, any potential strategic benefits, synergies or opportunities expected as a result of such acquisition, and any projected impacts from the Horizon acquisition on our acquisition-related expenses going forward), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico , and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as COVID-19, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. There can be no guarantee that we will be able to realize any of the strategic benefits, synergies or opportunities arising from the Horizon acquisition, and such benefits, synergies or opportunities may take longer to realize than expected. We may not be able to successfully integrate Horizon, and such integration may take longer, be more difficult or cost more than expected. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our environmental, social and governance objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. CONTACT: Amgen, Thousand Oaks Elissa Snook , 609-251-1407 (media) Justin Claeys , 805-313-9775 (investors) View original content to download multimedia: https://www.prnewswire.com/news-releases/amgen-announces-2025-first-quarter-dividend-302328180.html SOURCE Amgen

Van Lith scores 17 to help No. 11 TCU women beat Brown 79-47AP Sports SummaryBrief at 6:06 p.m. ESTVan Lith scores 17 to help No. 11 TCU women beat Brown 79-47

Former US President Jimmy Carter dies at 100Didi Hamann names his two ‘favourites’ to win the Champions League

TORONTO — Canada's main stock index lost more than 100 points Tuesday ahead of an expected interest rate cut Wednesday, while U.S. markets were also down. The S&P/TSX composite index closed down 121.09 points at 25,504.33. In New York, the Dow Jones industrial average was down 154.10 points at 44,247.83. The S&P 500 index was down 17.94 points at 6,034.91, while the Nasdaq composite was down 49.45 points at 19,687.24. “Relative to the churn we have seen in the markets the last few days ... today being a little bit of a boring day would be fairly welcome for many investors,” said Stephen Duench, vice-president and portfolio manager for AGF Investments Inc. Wednesday is set to be more exciting, with an interest rate cut expected in Canada and important consumer inflation data coming in the U.S. “I do expect a little bit more fireworks tomorrow,” said Duench. The Bank of Canada is widely expected to announce an outsized cut Wednesday of half a percentage point, he said. “Anything other than that would be a surprise.” The U.S. Federal Reserve has its last decision of the year scheduled for next week, and market watchers are leaning toward a smaller quarter-percentage-point cut there, said Duench. It would be the third cut this year after the central bank hiked rates to a two-decade high to fight inflation. The inflation report will be the last significant data point before the central bank’s decision, Duench said. If the inflation report shows price growth is proving more stubborn than expected, that could change the Fed’s thinking on rates next week, he said. “Maybe that's part of the reason we've seen churn in the market the last few days in the U.S.” Beneath the surface, there was some movement in the tech sector, where Oracle sank 6.7 per cent after its latest earnings report missed expectations. Meanwhile, Google's stock price rose by more than five per cent. The company on Tuesday unveiled its new chip meant for quantum computing. Duench said after the advent of artificial technology led a rally earlier this year, quantum computing could be another frontier for investors to keep an eye on. The Canadian dollar traded for 70.59 cents US compared with 70.77 cents US on Monday. The January crude oil contract was up 12 cents at US$68.59 per barrel and the January natural gas contract was down two cents at US$3.16 per mmBTU. The February gold contract was up US$32.60 at US$2,718.40 an ounce and the March copper contract was down less than a penny at US$4.27 a pound. — With files from The Associated Press This report by The Canadian Press was first published Dec. 10, 2024. Companies in this story: (TSX:GSPTSE, TSX:CADUSD) Rosa Saba, The Canadian Press

LOS ANGELES — He’d been battered for weeks, lingering on the turf in pain at various points in previous wins over Nebraska and UCLA, always game enough to return a few players later after gingerly limping off. But running back Woody Marks, long USC’s Iron Man at running back, couldn’t return after another blow Saturday against Notre Dame. After a first-quarter handoff for nine yards, Marks laid on the turf for a few beats before stumbling to his feet, appearing slightly disoriented as he entered a medical tent on USC’s sideline. He eventually returned to the sideline as redshirt freshman Quinten Joyner took his place, but walked off into the Los Angeles Memorial Coliseum tunnel at the two-minute mark of the first half as the CBS broadcast reported he’d be out for the rest of the afternoon . It was a massive loss for USC’s offense, and could’ve served as the end of Marks’ time in a Trojans jersey depending on his bowl-game decision. If so, what a run it has been for the Mississippi State transfer: finishing with 1,133 yards on the ground in 12 games, putting together one of the more complete seasons by any USC running back in recent memory. Senior Day They came marching one by one down the barrel of the Coliseum, adorned with wreaths of honor, USC’s Easton Mascarenas-Arnold and Jaylin Smith and Woody Marks all exchanging hugs with Lincoln Riley as an early crowd erupted in claps for its program pillars. It was a moment of levity, USC honoring beloved seniors Saturday afternoon on the final day of its regular season. It was also, however, a sobering reality. With Mascarenas-Arnold, Smith and Marks went 138 combined tackles and four interceptions and 1,421 yards from scrimmage; with left guard Emmanuel Pregnon and center Jonah Monheim went two crucial pieces of a much-improved Trojans offensive line. Walking out from the tunnel on Senior Day, certainly, doesn’t provide an end-all, be-all on players’ futures. But it gave a hint, certainly, that several names who still carried eligibility – Mascarenas-Arnold, Smith, wide receiver Kyron Hudson – could be moving on come the winter. “We’ll have a few guys, obviously, who will have some decisions to make on if they go pro or if they stay and play another year,” Riley said Tuesday, when asked how he might adjust USC’s offensive personnel in the offseason. “Not a ton, but we’ve got a couple guys that have those decisions. We’ll just see. We’re going to try to get the right talent in here.” USC will be hard-pressed to add that talent, certainly, as eyes turn ahead to a bowl-game slot and the 2025 season. If every player honored on USC’s announced Senior Day graphic moves on , either via the NFL draft or the transfer portal, USC stands to lose 17 players from its offense, defense and special teams who started Saturday against Notre Dame. Here’s the breakdown: Offense: WR Kyle Ford, TE Lake McRee, RB Woody Marks, C Jonah Monheim, LG Emmanuel Pregnon, RT Mason Murphy, WR Kyron Hudson Defense: S Akili Arnold, LB Easton Mascarenas-Arnold, LB Mason Cobb, CB Jacobe Covington, DT Nate Clifton, DT Gavin Meyer, CB Jaylin Smith, CB Greedy Vance Jr. Special teams: P Eddie Czaplicki, K Michael Lantz It’s still probable, as Riley mentioned, that a few of those names elect to stay at USC for another season. McRee, Murphy and Hudson, in particular, are redshirt juniors and would likely see their draft stock elevated by a return for a prominent senior year at USC. Still, the Trojans will have major work to do in the transfer portal and with depth development this offseason, particularly at center, replacing Monheim, and cornerback. Caleb Williams returns Not a day after the NFL’s Chicago Bears canned head coach Matt Eberflus following a 23-20 loss to the Detroit Lions , former star quarterback and No. 1 overall draft pick Caleb Williams was back at the Coliseum on for his USC jersey-retirement ceremony in a palate cleanser of a Saturday afternoon. Williams, the Heisman Trophy winner who conquered opposing defenses and NIL riches in his time at USC, took a moment to thank the Coliseum crowd upon leading the Trojans out of the tunnel Saturday. “Number 13 is back,” Williams announced over the PA, speaking in a microphone to wide cheers. “And not only – is in the rafters now, because of all of you.”Daily Horoscope Read today's horoscope, December 1, 2024. Today we'll be taking a closer look at what the stars have in store for each of the 12 zodiac signs. Our astrologer has analyzed the movements of the planets and the alignment of the stars to bring you the most accurate and up-to-date horoscope predictions for the day ahead. Whether you're looking for guidance on love, career, or simply a heads up on what to expect, this has got you covered. Let's dive in to see what the cosmos have in store for you today. Aries Today is a good day; your financial health is likely to improve. You may benefit from past investments. You might gain control over spending on unnecessary items, which could boost your savings. Lovebirds are advised to be polite in conversations with their partners; otherwise, conflicts may arise. Taurus Today, you are blessed by the Moon; it’s a good day for you. You have vitality and energy and may enjoy your work. Romantic moments with your spouse could improve family harmony. You are likely to plan and initiate a new project; your perfectionism may help you design an effective flowchart. Job aspirants may find a good opportunity. Lovebirds are advised to avoid discussing trivial topics. Gemini Today, you may feel disappointed. It is advised to control your arrogance; otherwise, your words could lead to losses or misunderstandings. Lovebirds should be cautious in discussions to avoid negatively affecting their relationship. Cancer Today, you are blessed by the Moon, and new sources of income may open up. Past investments might start yielding profits. Losses could turn into gains, boosting your financial health. Health issues concerning your parents may be resolved. Leo Today, you may feel very happy and will likely be busy at work. Your seniors may appreciate your efforts, and you might experience changes in your position, place, or responsibilities at work, possibly in the form of a promotion. Your opponents and hidden enemies may now be under control. Singles and lovebirds may make important decisions about marriage with the support of relatives or friends. Virgo Today, the messy situations from previous days may come under control as you are blessed by the Moon. You can now begin pending tasks. With blessings, your hard work may be rewarded. Gains in business might improve your finances. You may spend money on artifacts or literature and might even plan for overseas travel. Libra Today, you may be occupied with family matters. You might explore additional sources of income. Your interest in artifacts, movies, or glamour may enhance your creativity. Lovebirds may have clarity regarding their relationships. Students are likely to make progress toward their career goals. Scorpio Today, you may not feel well and could face health issues that affect your professional and domestic life. Spouse-related health concerns might upset you. Your patience may be tested repeatedly. It is advised to avoid making investments in new business projects to prevent losses. Students should avoid distractions and focus on their studies. Sagittarius Today, you are blessed by the positive Moon. You may feel healthy, and old health issues might be cured. Stuck funds may be recovered, and you might apply for a loan to purchase luxury items. Capricorn Today, you may feel dull, which could lead to laziness and carelessness. You might struggle to focus on work, and impatience could have a negative impact on you. Concerns about the health of your children or spouse might upset you. Avoid making investments in assets. Lovebirds should refrain from arguments about family matters. Aquarius Today, you may sense negative vibrations around you, making you feel unhappy. Avoid investing in worthless assets. Your friends may not be supportive, so manage your expectations to avoid further disappointment. Trust your intuition before making significant decisions today. Pisces Today, you may successfully implement business plans with the support of your subordinates. You might participate in social or family gatherings, which could expand your network. A short business trip may be on the horizon, bringing benefits in the near future. .

BEIRUT (AP) — Thousands of people fled the central Syrian city of Homs, the country’s third largest, as insurgents seized two towns on the outskirts Friday, positioning themselves for an assault on a potentially major prize in their march against President Bashar Assad. The move, reported by pro-government media and an opposition war monitor, was the latest in the stunning advances by opposition fighters over the past week that have so far met little resistance from Assad’s forces. A day earlier, fighters captured the central city of Hama , Syria’s fourth largest, after the army said it withdrew to avoid fighting inside the city and spare the lives of civilians. The insurgents, led by the jihadi Hayat Tahrir al-Sham group, or HTS, have vowed to march to Homs and the capital, Damascus, Assad’s seat of power. Videos circulating online showed a highway jammed with cars full of people fleeing Homs, a city with a large population belonging to Assad’s Alawite sect, seen as his core supporters. If Assad’s military loses Homs, it could be a crippling blow. The city, parts of which were controlled by insurgents until 2014, stands at an important intersection between Damascus and Syria’s coastal provinces of Latakia and Tartus, where Assad enjoys wide support. Homs province is Syria’s largest in size and borders Lebanon, Iraq and Jordan. Pressure on the government intensified from multiple directions. Opposition protesters stormed security posts and army positions in the southern province of Sweida, opposition activists said. U.S.-backed Kurdish forces who control eastern and northeastern Syria began to encroach on government-held territory. After years of largely being bottled up in a northwest corner of the country, the insurgents burst out a week ago, captured the northern city of Aleppo, Syria’s largest , and have kept advancing since. Government troops have repeatedly fallen back. The sudden offensive has flipped the tables on a long-entrenched stalemate in Syria’s nearly 14-year-old civil war. Along with HTS, the fighters include forces of an umbrella group of Turkish-backed Syrian militias called the Syrian National Army. Turkey has denied backing the offensive , though experts say insurgents would not have launched it without the country's consent. HTS’s leader, Abu Mohammad al-Golani, told CNN in an exclusive interview Thursday from Syria that Assad’s government was on the path to falling, propped up only by Russia and Iran. “The seeds of the regime’s defeat have always been within it,” he said. “But the truth remains, this regime is dead.” A key question about Assad’s ability to fight back is how much top ally Russia — whose troops back Assad’s forces — will throw support his way at a time when it is tied up in the war in Ukraine. Russian Foreign Minister Sergey Lavrov said he planned to discuss the developments in Syria with his Turkish and Iranian counterparts at a meeting Friday in the Qatari capital, Doha. In an interview with former Fox News host Tucker Carlson, he said international actors were backing the insurgents’ advances and that he would discuss “the way to cut the channels of financing and arming them.” Meanwhile, Russia’s embassy in Syria issued a notice reminding Russian citizens that they may use commercial flights to leave the country “in view of the difficult military-political situation.” The foreign ministers of Iran, Iraq and Syria — three close allies — gathered Friday in Baghdad to consult on the rapidly changing war. Syrian Foreign Minister Bassam Sabbagh said the current developments may pose “a serious threat to the security of the region as a whole.” The insurgent fighters on Friday took over the central towns of Rastan and Talbiseh, putting them 5 kilometers (3 miles) from Homs, according to the Britain-based Syrian Observatory for Human Rights, an opposition war monitor. “The battle of Homs is the mother of all battles and will decide who will rule Syria,” said Rami Abdurrahman, the Observatory’s chief. Pro-government Sham FM said the insurgents entered Rastan and Talbiseh without facing any resistance. There was no immediate comment from the Syrian military. The Observatory said Syrian troops had left Homs. But the military denied that in comments reported by the state news agency SANA, saying troops were reinforcing their positions in the city and were “ready to repel” any assault. In eastern Syria, the Kurdish-led Syrian Democratic Forces coalition said it had moved into the government-held half of the city of Deir el-Zour, apparently without resistance. One of the main cities in the east, Deir el-Zour had long been split between the government on the western side of the Euphrates River and the SDF on the eastern side. The SDF also said it took control of further parts of the border with Iraq. That appeared to bring it closer to the government-held Boukamal border crossing. The crossing is a vital for the government because it is the gateway to the corridor to Iran, a supply line for Iran-backed fighters, including Lebanon’s Hezbollah. At the same time, insurgents seized Syria’s sole crossing to Jordan, according to opposition activists. Jordan announced it was closing its side of the crossing. Lebanon also closed all but one of its border crossings with Syria. The opposition assault has struck a blow to Syria’s already decrepit economy. On Friday, the U.S. dollar was selling on Syria’s parallel market for about 18,000 pounds, a 25% drop from a week ago. When Syria’s conflict erupted in March 2011, a dollar was valued at 47 pounds. The drop further undermines the purchasing power of Syrians at a time when the U.N. has warned that 90% of the population is below the poverty line. Syria’s economy has been hammered for years by the war, Western sanctions, corruption and an economic meltdown in neighboring Lebanon, Syria’s main gate to the outside world. Damascus residents told The Associated Press that people are rushing to markets to buy food, fearing further escalation. The worsening economy could be undermining the ability of Syria’s military to fight, as the value of soldiers’ salaries melts away while the insurgents are flush with cash. Syria’s military has not appeared to put up a cohesive counteroffensive against the opposition advances. SANA on Friday quoted an unnamed military official as saying the Syrian and Russian air forces were striking insurgents in Hama province, killing dozens of fighters. Syria’s defense minister said in a televised statement late Thursday that government forces withdrew from Hama as “a temporary tactical measure” and vowed to gain back lost areas. “We are in a good position on the ground,” Gen. Ali Mahmoud Abbas said, saying troops remained “at the gates of Hama.” He spoke before the opposition advanced further south toward Homs. He said the insurgents, whom he described as “takfiri” or Muslim extremists, are backed by foreign countries. He did not name the countries but appeared to be referring to Turkey and the United States. Associated Press writers Albert Aji in Damascus, Syria, and Suzan Fraser in Ankara, Turkey, contributed to this report.

Lake is mayor Adam Shultz's Labor of love

‘Burn people at the stake’: Ange slams cancel culture after ‘harsh’ Bentancur ban

NEW YORK (AP) — U.S. stock indexes drifted lower in the runup to the highlight of the week for the market, the latest update on inflation. The S&P 500 slipped 0.3% Tuesday and marked its first back-to-back losses in three weeks. The Dow Jones Industrial Average fell 0.3%, and the Nasdaq composite also fell 0.3%. Oracle dragged on the market after reporting weaker growth than analysts expected. Treasury yields rose in the bond market ahead of Wednesday’s inflation report, which will be among the final big pieces of data before the Federal Reserve’s meeting on interest rates next week. THIS IS A BREAKING NEWS UPDATE. AP’s earlier story follows below. NEW YORK (AP) — U.S. stock indexes are drifting lower Tuesday in the runup to the highlight of the week for the market, the latest update on inflation that’s coming on Wednesday. The S&P 500 dipped by 0.2% in late trading, a day after pulling back from its latest all-time high . The index is on track for its first back-to-back losses in more than three weeks, as momentum slows following a big rally that has it on track for one of its best years of the millennium . The Dow Jones Industrial Average was down by 7 points, or less than 0.1%, with roughly an hour remaining in trading, and the Nasdaq composite fell 0.3%. Tech titan Oracle dragged on the market and sank 7.8% after reporting growth for the latest quarter that fell just short of analysts’ expectations. It was one of the heaviest weights on the S&P 500, even though CEO Safra Catz said the company saw record demand related to artificial-intelligence technology for its cloud infrastructure business, which trains generative AI models. AI has been a big source of growth that’s helped many companies’ stock prices skyrocket. Oracle’s stock had already leaped nearly 81% for the year coming into Tuesday, which raised the bar of expectations for its profit report. C3.ai fell 2.1% despite reporting a smaller loss for the latest quarter than analysts expected. The AI software company increased its forecast for how big a loss it expects to take this fiscal year from its operations. In the bond market, Treasury yields ticked higher ahead of Wednesday’s report on the inflation that U.S. consumers are feeling. Economists expect it to show roughly similar increases as the month before. That and a report on Thursday about inflation at the wholesale level will be the final big pieces of data the Federal Reserve will get before its meeting next week, where many investors expect the year’s third cut to interest rates . The Fed has been easing its main interest rate from a two-decade high since September to lift the slowing jobs market, after bringing inflation nearly down to its 2% target. Lower rates would help give support to the economy, but they could also provide more fuel for inflation. The yield on the 10-year Treasury rose to 4.22% from 4.20% late Monday. Even though the Fed has been cutting its main interest rate, mortgage rates have been more stubborn and have been volatile since the autumn. That has hampered the housing industry, and homebuilder Toll Brothers’ stock fell 5.2% even though it beat analysts’ expectations for profit and revenue in the latest quarter. CEO Douglas Yearley Jr. said the luxury builder has been seeing strong demand since the start of its fiscal year six weeks ago, an encouraging signal as it approaches the beginning of the spring selling season in mid-January Elsewhere on Wall Street, Alaska Air Group soared 13.6% after raising its forecast for profit in the current quarter. The airline said demand for flying around the holidays has been stronger than expected. It also approved a plan to buy back up to $1 billion of its stock, along with new service from Seattle to Tokyo and Seoul . Boeing climbed 5.2% after saying it's resuming production of its bestselling plane , the 737 Max, for the first time since 33,000 workers began a seven-week strike that ended in early November. Vail Resorts rose 2.7% after the ski resort operator reported a narrower first-quarter loss than expected in what is traditionally its worst quarter. In stock markets abroad, indexes were mixed in China after the world’s second-largest economy said its exports rose by less than expected in November. Stocks rose 0.6% in Shanghai but fell 0.5% in Hong Kong. ___ AP Business Writers Matt Ott and Elaine Kurtenbach contributed. Stan Choe, The Associated Press